1. People

Annie Killoran, MD, MS

Clinical Associate Professor of Neurology

Current Positions

  • Clinical Associate Professor of Neurology
  • Clinical Associate Professor of Psychiatry

Education

  • MS in Pathology and Molecular Medicine, Queen’s University, Kingston, Canada
  • MD in Medicine, University College Dublin, National University of Ireland, Dublin, Ireland
  • Resident in Neurology, Michigan State University, East Lansing, Michigan, United States
  • Fellow in Movement Disorders - Experimental Therapeutics, University of Rochester Medical Center, Rochester, New York, United States

Licenses & Certifications

  • Medical License, West Virginia Medical Board, West Virginia

Selected Publications

  • Killoran, A. Biomarkers in Huntington Disease. In Neurodegenerative Diseases Biomarkers. PV Peplow, B Martinez and TA Gennarelli (eds.) Neuromethods, vol 173. 10/2021
  • Schultz JL, Nopoulos PC, Killoran A, Kamholz JA. Statin Use and Delayed Onset of Huntington Disease.  Movement Disorders. 2019;34(2):281-285
  • Schultz, J. L., Kamholz, J. A., Napoulos, P. C. & Killoran, A. Comparing risperidone and olanzapine to tetrabenazine for the management of chorea in Huntington Disease. Movement Disorders Clinical Practice.
  • Schultz, J. L., Nopoulos, P. C., Killoran, A. & Kahmolz, J. A. (2018). Statin Use and Delayed Onset of Huntington Disease. Movement Disorders.
  • Mendez, A. A., Bosco, A., Abdel-Wahed, L., Palmer, K., Jones, K. A. & Killoran, A. (2018). A Fatal Case of HSV Encephalitis with Two False-Negative PCRs. Case Reports in Neurology. Case Rep Neurol.
  • Schultz, J. L., Killoran, A., Napoulos, P. C., Chabal, C. C., Moser, D. J. & Kamholz, J. A. (2018). Evaluating Depression and Suicidality in Tetrabenazine Users with Huntington Disease. Enroll-HD Congress.
  • Killoran, A. (2017). The Clinical Features of Huntington's Disease. In Hughes, C. (Eds.) Huntington's Disease: Prevalence, Pathogenesis and Treatment. Nova Science Publishers.
  • Killoran, A. & Biglan, K. (2016). Biomarkers for Huntington’s disease: a brief overview. Journal of Rare Disease Research & Treatment. 1 (2) 46-50.
  • Killoran, A. & Biglan, K. M. (2014). Current therapeutic options for Huntington's disease: good clinical practice versus evidence-based approaches?. Movement disorders : official journal of the Movement Disorder Society 29 (11) 1404-13. DOI: 10.1002/mds.26014. PMID: 25164707.
  • Killoran, A. & Biglan, K. M. (2014). Movement, Facial. In Ettinger, A. & Weisbrot, D. (Eds.) Neurological Differential Diagnosis: A Case-based Approach. pp. 247-249. Cambridge University Press. PMID: 1107014557.

People